#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	17866	16S	1529	1529	100.0	16S.l6.c30.ctg.1	2184	807.2	1	SNP	n	C1184T	0	.	.	1184	1184	C	1411	1411	C	1049	C	1010	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	33766	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3449	968.9	0	.	n	.	0	T695C	SNP	695	695	T	965	965	C	999	C	954	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	33766	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3449	968.9	0	.	n	.	0	A790G	SNP	790	790	A	1060	1060	G	1043	G,A,C	746,267,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	33766	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3449	968.9	0	.	n	.	0	G1337A	SNP	1337	1337	G	1607	1607	A	1086	A,G	1042,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	33766	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3449	968.9	0	.	n	.	0	T1971C	SNP	1971	1971	T	2241	2241	C	1048	C	1010	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	33766	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3449	968.9	1	SNP	n	A2045G	0	.	.	2045	2045	A	2315	2315	A	1039	A,G	1012,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	33766	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3449	968.9	1	SNP	n	C2597T	0	.	.	2597	2597	C	2867	2867	C	1084	C	1047	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_L_00516	folP.WHO_L_00516	1	1	27	2292	folP	855	855	100.0	folP.l15.c17.ctg.1	1564	145.1	1	SNP	p	R229S	0	.	.	685	687	CGC	1017	1019	CGC	217;216;216	C;G;C	213;213;213	folP.WHO_L_00516:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	6082	gyrA	2751	2751	99.89	gyrA.l15.c4.ctg.1	3341	180.4	1	SNP	p	S91F	0	.	.	271	273	TCC	574	576	TCC	217;214;214	T;C;C	212;209;207	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	6082	gyrA	2751	2751	99.89	gyrA.l15.c4.ctg.1	3341	180.4	1	SNP	p	D95G	0	.	.	283	285	GAC	586	588	GAC	216;216;214	G;A;C	211;206;207	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	6082	gyrA	2751	2751	99.89	gyrA.l15.c4.ctg.1	3341	180.4	1	SNP	p	D95N	0	.	.	283	285	GAC	586	588	GAC	216;216;214	G;A;C	211;206;207	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_K_01388	mtrR.WHO_K_01388	1	1	27	1990	mtrR	633	633	100.0	mtrR.l15.c30.ctg.1	1449	136.3	1	SNP	p	G45D	1	.	.	133	135	GAC	553	555	GAC	243;240;239	G;A;C	235;230;230	mtrR.WHO_K_01388:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	1106	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c4.ctg.1	987	110.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	27	5936	parC	2304	2304	99.83	parC.l15.c17.ctg.1	2816	207.8	1	SNP	p	D86N	0	.	.	256	258	GAC	467	469	GAC	224;224;229	G;A;C	215;211;219	parC.WHO_V_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	27	5936	parC	2304	2304	99.83	parC.l15.c17.ctg.1	2816	207.8	1	SNP	p	S88P	0	.	.	262	264	TCC	473	475	TCC	227;228;228	T;C;C	220;219;221	parC.WHO_V_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4896	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2635	184.0	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1604	1606	GGC	245;243;242	G;G;C	240;237;234	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.9.001	penA.9.001	1	1	539	4536	penA	1749	1749	99.94	penA.l15.c17.ctg.1	2357	189.5	1	SNP	p	A502V	1	A502V	NONSYN	1504	1506	GCG	1704	1706	GTG	237;233;234	G,C;T,G;G	220,1;180,13;219	penA.9.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	539	4536	penA	1749	1749	99.94	penA.l15.c17.ctg.1	2357	189.5	1	SNP	p	A311V	0	.	.	931	933	GCA	1131	1133	GCA	247;245;249	G,T;C;A	235,1;231;239	penA.9.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	539	4536	penA	1749	1749	99.94	penA.l15.c17.ctg.1	2357	189.5	1	SNP	p	I312M	0	.	.	934	936	ATC	1134	1136	ATC	251;252;253	A;T;C	239;239;242	penA.9.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	539	4536	penA	1749	1749	99.94	penA.l15.c17.ctg.1	2357	189.5	1	SNP	p	V316T	0	.	.	946	948	GTG	1146	1148	GTG	255;254;253	G;T;G	242;236;240	penA.9.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	539	4536	penA	1749	1749	99.94	penA.l15.c17.ctg.1	2357	189.5	1	SNP	p	V316P	0	.	.	946	948	GTG	1146	1148	GTG	255;254;253	G;T;G	242;236;240	penA.9.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	539	4536	penA	1749	1749	99.94	penA.l15.c17.ctg.1	2357	189.5	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1650	1652	ACC	243;244;243	A,C;C;C,G	225,1;232;229,1	penA.9.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	539	4536	penA	1749	1749	99.94	penA.l15.c17.ctg.1	2357	189.5	1	SNP	p	G543S	0	.	.	1627	1629	GGC	1827	1829	GGC	193;193;192	G;G;C	186;188;183	penA.9.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	539	4536	penA	1749	1749	99.94	penA.l15.c17.ctg.1	2357	189.5	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1836	1838	GGC	192;191;191	G;G;C	183;178;177	penA.9.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	539	4536	penA	1749	1749	99.94	penA.l15.c17.ctg.1	2357	189.5	1	SNP	p	L552S	0	.	.	1654	1656	CTG	1854	1856	CTG	180;180;179	C,G;T,G;G	143,13;142,1;150	penA.9.001:1:1:L552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_F_00106	ponA.WHO_F_00106	1	1	539	6718	ponA	2397	2397	99.96	ponA.l15.c4.ctg.1	3004	221.1	1	SNP	p	L421P	1	L421P	NONSYN	1261	1263	CTG	1572	1574	CCG	242;244;242	C;C;G	227;238;229	ponA.WHO_F_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2806	porA	1146	1146	99.83	porA.l15.c4.ctg.1	1838	151.0	0	.	p	.	0	S22G	NONSYN	64	66	AGC	383	385	GGC	171;171;172	G;G;C	162;161;165	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2806	porA	1146	1146	99.83	porA.l15.c4.ctg.1	1838	151.0	0	.	p	.	0	M83fs	FSHIFT	247	247	A	565	565	C	201	C	188	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3388	porB1b	1047	1047	99.04	porB1b.l15.c17.ctg.1	1378	240.4	0	.	p	.	0	G120N	NONSYN	358	360	GGC	527	529	AAC	259;257;262	A;A;C	255;252;256	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3388	porB1b	1047	1047	99.04	porB1b.l15.c17.ctg.1	1378	240.4	0	.	p	.	0	E212G	NONSYN	634	636	GAA	803	805	GGA	276;274;271	G;G;A	267;269;260	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3388	porB1b	1047	1047	99.04	porB1b.l15.c17.ctg.1	1378	240.4	0	.	p	.	0	Y216_S217del	DEL	646	646	T	815	815	T	265	T	261	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3388	porB1b	1047	1047	99.04	porB1b.l15.c17.ctg.1	1378	240.4	0	.	p	.	0	D294N	NONSYN	880	882	GAT	1043	1045	AAT	275;278;278	A,C,G;A;T	261,1,1;265;264	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3388	porB1b	1047	1047	99.04	porB1b.l15.c17.ctg.1	1378	240.4	1	SNP	p	D121N	0	.	.	361	363	GAC	530	532	GAC	257;259;260	G;A;C	251;249;255	porB1b.WHO_P_02204c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3388	porB1b	1047	1047	99.04	porB1b.l15.c17.ctg.1	1378	240.4	1	SNP	p	A121D	1	.	.	361	363	GAC	530	532	GAC	257;259;260	G;A;C	251;249;255	porB1b.WHO_P_02204c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	12094	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4730	253.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1410	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	989	140.8	1	SNP	p	V57M	1	.	.	169	171	ATG	555	557	ATG	298;300;298	A;T;G	290;292;289	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
